Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Moderna (MRNA) stock is on the move Wednesday alongside positive results from its latest Phase 3 mRNA-1345 vaccine trial.

The post Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.